Human immunodeficiency virus downregulates podocyte apoE expression

被引:14
|
作者
Arora, Shitij [1 ]
Husain, Mohammad [1 ]
Kumar, Dileep [1 ]
Patni, Hitesh [1 ]
Pathak, Shresh [1 ]
Mehrotra, Devi [1 ]
Reddy, Vivek Kathi [1 ]
Reddy, Lalit Rajeev [1 ]
Salhan, Divya [1 ]
Yadav, Anju [1 ]
Mathieson, Peter W. [2 ]
Saleem, Moin A. [2 ]
Chander, Praveen N. [3 ]
Singhal, Pravin C. [1 ]
机构
[1] N Shore Long Isl Jewish Med Ctr, Feinstein Inst Med Res, Ctr Immunol, Manhasset, NY USA
[2] Univ Bristol, Childrens Renal Unit, Bristol, Avon, England
[3] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA
基金
英国医学研究理事会;
关键词
apolipoprotein E; pelecan; mesangial cells; HEPARAN-SULFATE PROTEOGLYCANS; APOLIPOPROTEIN-A-I; CHOLESTEROL TRANSPORT; ALZHEIMERS-DISEASE; METABOLIC SYNDROME; PEPTIDE ANALOGS; TRANSGENIC MICE; LIPID RAFTS; VIRAL ENTRY; HIV-1;
D O I
10.1152/ajprenal.90668.2008
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Arora S, Husain M, Kumar D, Patni H, Pathak S, Mehrotra D, Reddy VK, Reddy LR, Salhan D, Yadav A, Mathieson PW, Saleem MA, Chander PN, Singhal PC. Human immunodeficiency virus downregulates podocyte apoE expression. Am J Physiol Renal Physiol 297: F653-F661, 2009. First published June 24, 2009; doi:10.1152/ajprenal.90668.2008.-Apolipoprotein E (apoE) has been demonstrated to play an important role in providing protection against mesangial cell injury. In the present study, we evaluated the role of apoE and its associated downstream effects in human immunodeficiency virus (HIV)-associated nephropathy (HIVAN). Control (n = 6) and age-and sex-matched HIV-1 transgenic mice (Tg26, n = 6) were evaluated for their renal cortical expression of apoE. Renal tissue from Tg26 mice not only showed decreased apoE expression but also displayed downregulation of perlecan mRNA expression. In in vitro studies, conditionally immortalized human podocytes (CIHPs) were transduced with either NL4-3HIV (an HIV-1 construct lacking gag and pol, used for the development of Tg26 mouse model; NL4-3/CIHP) or empty vector (EV/CIHP); NL4-3/CIHPs and EV/CIHPs were studied for apoE mRNA expression. NL4-3/CIHPs showed reduction in apoE expression compared with EV/CIHPs. To evaluate the role of HIV-1 genes in the modulation of apoE expression, conditionally immortalized mouse podocytes (CIMPs) were transduced with individual HIV-1 gene constructs. Only nef-transduced CIMPs showed a decrease in apoE expression. To confirm this effect of nef in CIHPs, microarray analysis was performed in stable colonies of nef/CIHPs and EV/CIHPs. nef/CIHPs showed a 60% decrease in apoE and a 90% reduction in heparan sulfate mRNA expression. Moreover, nef transgenic mice showed a decrease in renal tissue expression of both apoE and perlecan. Both Tg26 and nef transgenic mice also showed areas of mesangial cell proliferation. These findings suggest that HIV-1-induced reduction in podocyte apoE expression and associated downregulation of podocyte perlecan might be contributing to mesangial cell (MC) phenotype in HIVAN.
引用
收藏
页码:F653 / F661
页数:9
相关论文
共 50 条
  • [31] Transcriptional Restriction of Human Immunodeficiency Virus Type 1 Gene Expression in Undifferentiated Primary Monocytes
    Dong, Chunsheng
    Kwas, Constance
    Wu, Li
    JOURNAL OF VIROLOGY, 2009, 83 (08) : 3518 - 3527
  • [32] High Expression of Antiviral Proteins in Mucosa from Individuals Exhibiting Resistance to Human Immunodeficiency Virus
    Milena Gonzalez, Sandra
    Andrea Taborda, Natalia
    Geronimo Feria, Manuel
    Arcia, David
    Aguilar-Jimenez, Wbeimar
    Zapata, Wildeman
    Teresa Rugeles, Maria
    PLOS ONE, 2015, 10 (06):
  • [33] Human immunodeficiency virus type 1 TAT protein induces adhesion molecule expression in astrocytes
    Woodman, SE
    Benveniste, EN
    Nath, A
    Berman, JW
    JOURNAL OF NEUROVIROLOGY, 1999, 5 (06) : 678 - 684
  • [34] Hepatitis B virus/human immunodeficiency virus coinfection: interaction among human immunodeficiency virus infection, chronic hepatitis B virus infection, and host immunity
    Li Yi-jia
    Wang Huan-ling
    Li Tai-sheng
    CHINESE MEDICAL JOURNAL, 2012, 125 (13) : 2371 - 2377
  • [35] Human Immunodeficiency Virus Promotes Mitochondrial Toxicity
    Rozzi, Summer J.
    Avdoshina, Valeria
    Fields, Jerel A.
    Trejo, Margarita
    Ton, Hoai T.
    Ahern, Gerard P.
    Mocchetti, Italo
    NEUROTOXICITY RESEARCH, 2017, 32 (04) : 723 - 733
  • [36] Human immunodeficiency virus antibodies and the vaccine problem
    Chiodi, F.
    Weiss, R. A.
    JOURNAL OF INTERNAL MEDICINE, 2014, 275 (05) : 444 - 455
  • [37] Management of human immunodeficiency virus in older people
    Eu, Beng
    Salleh, Ethan
    Sakko, Andrew
    Guaraldi, Giovanni
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2019, 48 (07) : 440 - 445
  • [38] Assembling the human immunodeficiency virus type 1
    Cimarelli, A
    Darlix, JL
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (07) : 1166 - 1184
  • [39] Human Immunodeficiency Virus Vaccine: Promise and Challenges
    Graciaa, Daniel S.
    Walsh, Stephen R.
    Rouphael, Nadine
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2024, 38 (03) : 475 - 485
  • [40] REGULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION
    CULLEN, BR
    ANNUAL REVIEW OF MICROBIOLOGY, 1991, 45 : 219 - 250